Skip to main content

Table 2 Description of Sample Characteristics

From: Depressive symptoms in long term care facilities in Western Canada: a cross sectional study

  Calgary (n = 2705) Edmonton (n = 2599) Fraser (n = 2749) Interior (n = 1318) Winnipeg (n = 2074) P Total (n = 11,445)
Demographics M SD M SD M SD M SD M SD   M SD
 Age 84.4 10.2 83.8 11.5 85.0 9.7 85.8 9.8 85.8 9.4 < 0.0001a 84.7 10.2
  N % N % N % N % N %   N %
 Female 1767 65.3 1691 65.1 1888 68.7 866 65.7 1550 74.7 < 0.0001b 7762 67.8
Marital status
 Never married 222 8.2 233 9.0 154 5.6 92 7.0 244 11.8 < 0.0001b 945 8.3
 Married 738 27.3 689 26.5 760 27.6 213 16.2 523 25.2 2923 25.5
 Widowed 1341 49.6 1223 47.1 1394 50.7 642 48.7 1113 53.7 5713 49.9
 Separated 60 2.2 59 2.3 75 2.7 220 16.7 25 1.2 439 3.8
 Divorced 292 10.8 176 6.8 278 10.1 137 10.4 161 7.8 1044 9.1
 Unknown 52 1.9 219 8.4 88 3.2 14 1.1 8 0.4 381 3.3
Comorbidities
 Depressive symptoms 1102 40.8 922 35.5 382 13.9 375 28.5 314 15.1 < 0.0001b 3095 27.1
 Cognitive impairment 2264 83.7 2208 85.0 2178 79.2 1069 81.1 1614 77.8 < 0.0001b 9333 81.6
 Depressive symptoms and cognitive impairment 953 35.5 804 30.9 317 11.5 323 24.5 274 13.2 < 0.0001b 2671 23.3
 Diabetes mellitus 614 22.7 587 22.6 550 20.0 244 18.5 465 22.4 0.0031b 2460 21.5
 Thyroid disease 202 7.5 289 11.1 179 6.5 86 6.5 380 18.3 < 0.0001b 1136 9.9
 HTN 1488 55.0 1433 55.1 1338 48.7 612 46.4 1227 59.2 < 0.0001b 6098 53.3
 Stroke/TIA 568 21.0 597 23.0 590 21.5 308 23.4 483 23.3 0.1619b 2546 22.3
 Hemiplegia/hemiparesis 205 7.6 157 6.0 99 3.6 49 3.7 35 1.7 < 0.0001b 545 4.8
 Seizure disorder 152 5.6 160 6.2 144 5.2 61 4.6 104 5.0 0.2664b 621 5.4
 Cardiovascular disease 1039 38.4 1040 40.0 724 26.3 439 33.3 805 38.8 < 0.0001b 4047 35.4
 Cancer 222 8.2 283 10.9 122 4.4 41 3.1 227 10.9 < 0.0001b 895 7.8
 COPD/asthma 376 13.9 443 17.0 227 8.3 152 11.5 317 15.3 < 0.0001b 1515 13.2
 Renal failure 116 4.3 105 4.0 105 3.8 87 6.6 121 5.8 0.0002b 534 4.7
 Osteoporosis 225 8.3 295 11.4 183 6.7 72 5.5 280 13.5 < 0.0001b 1055 9.2
 Arthritis 583 21.6 550 21.2 390 14.2 263 20.0 702 33.8 < 0.0001b 2488 21.7
 Neurodegenerative disease 116 4.3 155 6.0 84 3.1 58 4.4 144 6.9 < 0.0001b 557 4.9
 Anxiety 95 3.5 109 4.2 60 2.2 51 3.9 271 13.1 < 0.0001b 586 5.1
 Bipolar 46 1.7 61 2.3 37 1.3 22 1.7 41 2.0 0.0908b 207 1.8
 Schizophrenia 90 3.3 74 2.8 48 1.7 25 1.9 75 3.6 < 0.0001b 312 2.7
 Visual impairment 380 14.0 544 20.9 375 13.6 142 10.8 288 13.9 < 0.0001b 1729 15.1
 Gastrointestinal disease 740 27.4 1017 39.1 181 6.6 150 11.4 297 14.3 < 0.0001b 2385 20.8
 Liver disease 31 1.1 26 1.0 16 0.6 16 1.2 14 0.7 0.0848b 103 0.9
 Fecal incontinence 1572 58.1 1926 74.1 1250 45.5 525 39.8 941 45.4 < 0.0001b 6214 54.3
 Urinary incontinence 2043 75.5 2216 85.3 1733 63.0 872 66.2 1363 65.7 < 0.0001b 8227 71.9
 Indwelling catheter 137 5.1 174 6.7 87 3.2 72 5.5 75 3.6 < 0.0001b 545 4.8
 Responsive behaviors 1362 50.4 1434 55.2 1050 38.2 582 44.2 778 37.5 < 0.0001b 5206 45.5
 Fell in past 30 days 428 15.8 392 15.1 373 13.6 210 15.9 313 15.1 0.1405b 1716 15.0
 Stag 2+ pressure ulcer 157 5.8 200 7.7 119 4.3 50 3.8 65 3.1 < 0.0001b 591 5.2
 Stage 2+ stasis ulcer 157 5.8 200 7.7 119 4.3 50 3.8 65 3.1 < 0.0001b 591 5.2
 Hip fracture in last 180 days 48 1.8 42 1.6 23 0.8 10 0.8 18 0.9 0.0015b 141 1.2
 Traumatic brain injury 63 2.3 78 3.0 56 2.0 36 2.7 25 1.2 < 0.0001b 258 2.3
 Aphasia 172 6.4 329 12.7 91 3.3 30 2.3 34 1.6 < 0.0001b 656 5.7
 Daily or excruciating pain 179 6.6 196 7.5 345 12.6 188 14.3 258 12.4 < 0.0001b 1166 10.2
  1. aP value is based on an Analysis of Variance (ANOVA)
  2. bP value is based on a Fisher’s Exact test
  3. Bold entries is meant to indicate where the p value is significant